Abstract:We analyzed the costs to a hospital of providing complete home parenteral nutrition (HPN) services for eight patients. Identified cost components include patient training, equipment, supplies, and follow-up. The average annual cost of maintaining parenteral nutrition at home was 73% lower than it would have been in the hospital. The establishment of private companies to provide patients with HPN supplies and services will reduce the financial burden of HPN programs for hospitals.
“…The demographics of these patients were similar to those included in the cost analysis part of the study with respect to age (median [range]: HEN: 51 [24 to 59] years; HPN: 56 [25 to 74] years), sex distribution (HEN: men, 3; women, 7; HPN: men, 8; women, 14), and indication for therapy. The indication for therapy was self-reported with the HPN patients citing short bowel syndrome (17), inflammatory bowel disease (10), Behqet's disease (1), radiation enteritis (1), and gastrointestinal motility disorders (4). Because patients checked more than one reason, the numbers added up to more than 22 in the HPN group.…”
Section: Assessment Of Problems Relating To the Administration Of Hpementioning
The majority of the cost of therapy was associated with the direct provision of nutrition, although in some patients the hospitalization expenditure exceeded this cost. Home nutrition support had a significant negative impact on a patient's quality of life and lifestyle.
“…The demographics of these patients were similar to those included in the cost analysis part of the study with respect to age (median [range]: HEN: 51 [24 to 59] years; HPN: 56 [25 to 74] years), sex distribution (HEN: men, 3; women, 7; HPN: men, 8; women, 14), and indication for therapy. The indication for therapy was self-reported with the HPN patients citing short bowel syndrome (17), inflammatory bowel disease (10), Behqet's disease (1), radiation enteritis (1), and gastrointestinal motility disorders (4). Because patients checked more than one reason, the numbers added up to more than 22 in the HPN group.…”
Section: Assessment Of Problems Relating To the Administration Of Hpementioning
The majority of the cost of therapy was associated with the direct provision of nutrition, although in some patients the hospitalization expenditure exceeded this cost. Home nutrition support had a significant negative impact on a patient's quality of life and lifestyle.
“…1,2 Previous cost analyses have concluded that home PN reduces costs by 65%-81% when compared with hospital-based PN. [2][3][4][5][6][7] However, these estimates differ in the components of cost they included, the assumptions they made, and in the analytic perspective they assumed. For example, Curtas et al estimated personnel costs of home PN delivery but not the overall costs of care.…”
“…Maximum adaptation can only be reached when early enteral nutrition acts as a potent stimulator of mucosal growth [25]. The period of adaptation typically lasts for about 1 year in adults and up to 4 years in children [26,27]. It is commonly believed that patients will remain on TPN if enteral autonomy has not been regained by that time.…”
Survival and management of patients with irreversible intestinal failure has been made possible by the development of total parenteral nutrition (TPN). Despite the progress of TPN severe and even fatal complications might occur. Different non-surgical and surgical therapies can be employed to either improve intestinal function or restore enteral autonomy to obviate the need for TPN. A comprehensive review of the pertinent literature on different treatment modalities for short-bowel syndrome and our own experience are presented to judge long-term benefit and make recommendations on up-to-date surgical management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.